img

Global Drug Interactions Checker Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug Interactions Checker Market Research Report 2024

According to MRAResearch’s new survey, global Drug Interactions Checker market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drug Interactions Checker market research.
Key companies engaged in the Drug Interactions Checker industry include Medscape, WebMD, DrugBank, RxList, Liverpool, DynaMed, CVS Caremark, MIMS Australia and Wolters Kluwer, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Drug Interactions Checker were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Drug Interactions Checker market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Interactions Checker market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Medscape
WebMD
DrugBank
RxList
Liverpool
DynaMed
CVS Caremark
MIMS Australia
Wolters Kluwer
BioConcepts
Kaiser Permanente
Medindia
Segment by Type
Software
Platform

Segment by Application


Medical School
Hospital
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Drug Interactions Checker report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Interactions Checker Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Software
1.2.3 Platform
1.3 Market by Application
1.3.1 Global Drug Interactions Checker Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Medical School
1.3.3 Hospital
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Interactions Checker Market Perspective (2018-2033)
2.2 Drug Interactions Checker Growth Trends by Region
2.2.1 Global Drug Interactions Checker Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Drug Interactions Checker Historic Market Size by Region (2018-2023)
2.2.3 Drug Interactions Checker Forecasted Market Size by Region (2024-2033)
2.3 Drug Interactions Checker Market Dynamics
2.3.1 Drug Interactions Checker Industry Trends
2.3.2 Drug Interactions Checker Market Drivers
2.3.3 Drug Interactions Checker Market Challenges
2.3.4 Drug Interactions Checker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Interactions Checker Players by Revenue
3.1.1 Global Top Drug Interactions Checker Players by Revenue (2018-2023)
3.1.2 Global Drug Interactions Checker Revenue Market Share by Players (2018-2023)
3.2 Global Drug Interactions Checker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Interactions Checker Revenue
3.4 Global Drug Interactions Checker Market Concentration Ratio
3.4.1 Global Drug Interactions Checker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Interactions Checker Revenue in 2022
3.5 Drug Interactions Checker Key Players Head office and Area Served
3.6 Key Players Drug Interactions Checker Product Solution and Service
3.7 Date of Enter into Drug Interactions Checker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Interactions Checker Breakdown Data by Type
4.1 Global Drug Interactions Checker Historic Market Size by Type (2018-2023)
4.2 Global Drug Interactions Checker Forecasted Market Size by Type (2024-2033)
5 Drug Interactions Checker Breakdown Data by Application
5.1 Global Drug Interactions Checker Historic Market Size by Application (2018-2023)
5.2 Global Drug Interactions Checker Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drug Interactions Checker Market Size (2018-2033)
6.2 North America Drug Interactions Checker Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Drug Interactions Checker Market Size by Country (2018-2023)
6.4 North America Drug Interactions Checker Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Interactions Checker Market Size (2018-2033)
7.2 Europe Drug Interactions Checker Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Drug Interactions Checker Market Size by Country (2018-2023)
7.4 Europe Drug Interactions Checker Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Interactions Checker Market Size (2018-2033)
8.2 Asia-Pacific Drug Interactions Checker Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Drug Interactions Checker Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Interactions Checker Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Interactions Checker Market Size (2018-2033)
9.2 Latin America Drug Interactions Checker Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Drug Interactions Checker Market Size by Country (2018-2023)
9.4 Latin America Drug Interactions Checker Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Interactions Checker Market Size (2018-2033)
10.2 Middle East & Africa Drug Interactions Checker Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Drug Interactions Checker Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Interactions Checker Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medscape
11.1.1 Medscape Company Detail
11.1.2 Medscape Business Overview
11.1.3 Medscape Drug Interactions Checker Introduction
11.1.4 Medscape Revenue in Drug Interactions Checker Business (2018-2023)
11.1.5 Medscape Recent Development
11.2 WebMD
11.2.1 WebMD Company Detail
11.2.2 WebMD Business Overview
11.2.3 WebMD Drug Interactions Checker Introduction
11.2.4 WebMD Revenue in Drug Interactions Checker Business (2018-2023)
11.2.5 WebMD Recent Development
11.3 DrugBank
11.3.1 DrugBank Company Detail
11.3.2 DrugBank Business Overview
11.3.3 DrugBank Drug Interactions Checker Introduction
11.3.4 DrugBank Revenue in Drug Interactions Checker Business (2018-2023)
11.3.5 DrugBank Recent Development
11.4 RxList
11.4.1 RxList Company Detail
11.4.2 RxList Business Overview
11.4.3 RxList Drug Interactions Checker Introduction
11.4.4 RxList Revenue in Drug Interactions Checker Business (2018-2023)
11.4.5 RxList Recent Development
11.5 Liverpool
11.5.1 Liverpool Company Detail
11.5.2 Liverpool Business Overview
11.5.3 Liverpool Drug Interactions Checker Introduction
11.5.4 Liverpool Revenue in Drug Interactions Checker Business (2018-2023)
11.5.5 Liverpool Recent Development
11.6 DynaMed
11.6.1 DynaMed Company Detail
11.6.2 DynaMed Business Overview
11.6.3 DynaMed Drug Interactions Checker Introduction
11.6.4 DynaMed Revenue in Drug Interactions Checker Business (2018-2023)
11.6.5 DynaMed Recent Development
11.7 CVS Caremark
11.7.1 CVS Caremark Company Detail
11.7.2 CVS Caremark Business Overview
11.7.3 CVS Caremark Drug Interactions Checker Introduction
11.7.4 CVS Caremark Revenue in Drug Interactions Checker Business (2018-2023)
11.7.5 CVS Caremark Recent Development
11.8 MIMS Australia
11.8.1 MIMS Australia Company Detail
11.8.2 MIMS Australia Business Overview
11.8.3 MIMS Australia Drug Interactions Checker Introduction
11.8.4 MIMS Australia Revenue in Drug Interactions Checker Business (2018-2023)
11.8.5 MIMS Australia Recent Development
11.9 Wolters Kluwer
11.9.1 Wolters Kluwer Company Detail
11.9.2 Wolters Kluwer Business Overview
11.9.3 Wolters Kluwer Drug Interactions Checker Introduction
11.9.4 Wolters Kluwer Revenue in Drug Interactions Checker Business (2018-2023)
11.9.5 Wolters Kluwer Recent Development
11.10 BioConcepts
11.10.1 BioConcepts Company Detail
11.10.2 BioConcepts Business Overview
11.10.3 BioConcepts Drug Interactions Checker Introduction
11.10.4 BioConcepts Revenue in Drug Interactions Checker Business (2018-2023)
11.10.5 BioConcepts Recent Development
11.11 Kaiser Permanente
11.11.1 Kaiser Permanente Company Detail
11.11.2 Kaiser Permanente Business Overview
11.11.3 Kaiser Permanente Drug Interactions Checker Introduction
11.11.4 Kaiser Permanente Revenue in Drug Interactions Checker Business (2018-2023)
11.11.5 Kaiser Permanente Recent Development
11.12 Medindia
11.12.1 Medindia Company Detail
11.12.2 Medindia Business Overview
11.12.3 Medindia Drug Interactions Checker Introduction
11.12.4 Medindia Revenue in Drug Interactions Checker Business (2018-2023)
11.12.5 Medindia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug Interactions Checker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Software
Table 3. Key Players of Platform
Table 4. Global Drug Interactions Checker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Drug Interactions Checker Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Drug Interactions Checker Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug Interactions Checker Market Share by Region (2018-2023)
Table 8. Global Drug Interactions Checker Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Drug Interactions Checker Market Share by Region (2024-2033)
Table 10. Drug Interactions Checker Market Trends
Table 11. Drug Interactions Checker Market Drivers
Table 12. Drug Interactions Checker Market Challenges
Table 13. Drug Interactions Checker Market Restraints
Table 14. Global Drug Interactions Checker Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug Interactions Checker Market Share by Players (2018-2023)
Table 16. Global Top Drug Interactions Checker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Interactions Checker as of 2022)
Table 17. Ranking of Global Top Drug Interactions Checker Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drug Interactions Checker Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug Interactions Checker Product Solution and Service
Table 21. Date of Enter into Drug Interactions Checker Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Interactions Checker Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug Interactions Checker Revenue Market Share by Type (2018-2023)
Table 25. Global Drug Interactions Checker Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Drug Interactions Checker Revenue Market Share by Type (2024-2033)
Table 27. Global Drug Interactions Checker Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug Interactions Checker Revenue Market Share by Application (2018-2023)
Table 29. Global Drug Interactions Checker Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Drug Interactions Checker Revenue Market Share by Application (2024-2033)
Table 31. North America Drug Interactions Checker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Drug Interactions Checker Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Drug Interactions Checker Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Drug Interactions Checker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Drug Interactions Checker Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Drug Interactions Checker Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Drug Interactions Checker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Drug Interactions Checker Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Drug Interactions Checker Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Drug Interactions Checker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Drug Interactions Checker Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Drug Interactions Checker Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Drug Interactions Checker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Drug Interactions Checker Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Drug Interactions Checker Market Size by Country (2024-2033) & (US$ Million)
Table 46. Medscape Company Detail
Table 47. Medscape Business Overview
Table 48. Medscape Drug Interactions Checker Product
Table 49. Medscape Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 50. Medscape Recent Development
Table 51. WebMD Company Detail
Table 52. WebMD Business Overview
Table 53. WebMD Drug Interactions Checker Product
Table 54. WebMD Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 55. WebMD Recent Development
Table 56. DrugBank Company Detail
Table 57. DrugBank Business Overview
Table 58. DrugBank Drug Interactions Checker Product
Table 59. DrugBank Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 60. DrugBank Recent Development
Table 61. RxList Company Detail
Table 62. RxList Business Overview
Table 63. RxList Drug Interactions Checker Product
Table 64. RxList Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 65. RxList Recent Development
Table 66. Liverpool Company Detail
Table 67. Liverpool Business Overview
Table 68. Liverpool Drug Interactions Checker Product
Table 69. Liverpool Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 70. Liverpool Recent Development
Table 71. DynaMed Company Detail
Table 72. DynaMed Business Overview
Table 73. DynaMed Drug Interactions Checker Product
Table 74. DynaMed Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 75. DynaMed Recent Development
Table 76. CVS Caremark Company Detail
Table 77. CVS Caremark Business Overview
Table 78. CVS Caremark Drug Interactions Checker Product
Table 79. CVS Caremark Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 80. CVS Caremark Recent Development
Table 81. MIMS Australia Company Detail
Table 82. MIMS Australia Business Overview
Table 83. MIMS Australia Drug Interactions Checker Product
Table 84. MIMS Australia Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 85. MIMS Australia Recent Development
Table 86. Wolters Kluwer Company Detail
Table 87. Wolters Kluwer Business Overview
Table 88. Wolters Kluwer Drug Interactions Checker Product
Table 89. Wolters Kluwer Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 90. Wolters Kluwer Recent Development
Table 91. BioConcepts Company Detail
Table 92. BioConcepts Business Overview
Table 93. BioConcepts Drug Interactions Checker Product
Table 94. BioConcepts Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 95. BioConcepts Recent Development
Table 96. Kaiser Permanente Company Detail
Table 97. Kaiser Permanente Business Overview
Table 98. Kaiser Permanente Drug Interactions Checker Product
Table 99. Kaiser Permanente Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 100. Kaiser Permanente Recent Development
Table 101. Medindia Company Detail
Table 102. Medindia Business Overview
Table 103. Medindia Drug Interactions Checker Product
Table 104. Medindia Revenue in Drug Interactions Checker Business (2018-2023) & (US$ Million)
Table 105. Medindia Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Interactions Checker Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Drug Interactions Checker Market Share by Type: 2022 VS 2033
Figure 3. Software Features
Figure 4. Platform Features
Figure 5. Global Drug Interactions Checker Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Drug Interactions Checker Market Share by Application: 2022 VS 2033
Figure 7. Medical School Case Studies
Figure 8. Hospital Case Studies
Figure 9. Other Case Studies
Figure 10. Drug Interactions Checker Report Years Considered
Figure 11. Global Drug Interactions Checker Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Drug Interactions Checker Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Drug Interactions Checker Market Share by Region: 2022 VS 2033
Figure 14. Global Drug Interactions Checker Market Share by Players in 2022
Figure 15. Global Top Drug Interactions Checker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Interactions Checker as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Drug Interactions Checker Revenue in 2022
Figure 17. North America Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Drug Interactions Checker Market Share by Country (2018-2033)
Figure 19. United States Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Drug Interactions Checker Market Share by Country (2018-2033)
Figure 23. Germany Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Drug Interactions Checker Market Share by Region (2018-2033)
Figure 31. China Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Drug Interactions Checker Market Share by Country (2018-2033)
Figure 39. Mexico Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Drug Interactions Checker Market Share by Country (2018-2033)
Figure 43. Turkey Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Drug Interactions Checker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Medscape Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 46. WebMD Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 47. DrugBank Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 48. RxList Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 49. Liverpool Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 50. DynaMed Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 51. CVS Caremark Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 52. MIMS Australia Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 53. Wolters Kluwer Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 54. BioConcepts Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 55. Kaiser Permanente Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 56. Medindia Revenue Growth Rate in Drug Interactions Checker Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed